Medics Autonomously Stopping Hemorrhage (MASH)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-PS-25-34
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AC12
Additional Details
The Defense Advanced Research Projects Agency (DARPA) has issued a solicitation (DARPA-PS-25-34) for the Medics Autonomously Stopping Hemorrhage (MASH) program, seeking innovative proposals to advance autonomous medical technologies for hemorrhage control in austere environments. This initiative is focused on developing demonstrator autonomous systems capable of stabilizing torso hemorrhage without the intervention of a surgeon at forward medical sites, thereby extending the window for definitive care to 48 hours or more.
The MASH program aims to revolutionize pre-hospital trauma care by integrating multi-modal automated bleed detection and localization with minimally invasive, robotic end effectors and advanced sensor technologies. The overarching objective is to autonomously stop lethal forms of torso hemorrhage, a leading cause of preventable death on the battlefield and in remote settings, and to provide a pathway for minimally invasive surgery (MIS) to enter the trauma market with fully autonomous capabilities.
Key requirements for this solicitation include the development of systems that can autonomously detect, localize, and control internal bleeding in the torso, leveraging advanced robotics and sensor integration. Proposals must demonstrate a clear approach to merging these technologies into a cohesive, minimally invasive solution that can operate reliably in forward-deployed or resource-limited environments. The expected deliverables include functional demonstrator systems that can be evaluated for their effectiveness in extending survivability and reducing the need for immediate surgical intervention.
This procurement is classified under NAICS code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and carries the Product Service Code AC12. The contracting entity is the Defense Advanced Research Projects Agency (DARPA), a federal office dedicated to pioneering advanced research for national security. Interested parties should direct inquiries and proposal submissions to the BAA Coordinator at [email protected].
The solicitation is currently active, with a posting date of August 10, 2025, and a response deadline of November 25, 2025. Contractors are advised that proposal abstracts must include Attachments A-C, as clarified in Amendment 1 and detailed in the solicitation documents. All relevant attachments and guidance are available through the official SAM.gov opportunity listing.
This opportunity is particularly suited for organizations with expertise in biotechnology R&D, medical robotics, autonomous systems, and trauma care innovation. Contractors should carefully review the solicitation and associated attachments to ensure alignment with the program’s technical objectives and submission requirements. No set-aside requirements or special considerations are specified in the provided information.
For further details and access to solicitation documents, interested parties should consult the official notice at: https://sam.gov/opp/95e047cddc80476c8e2bc97d23103156/view.
Documents7